Liver cancer: a promising avenue for more effective immunotherapies
Laval, February 14, 2024 – A research team of Canadian and French scientists, led by INRS professor Maya Saleh, has been investigating immunotherapy resistance in certain patients with hepatocellular carcinoma (HCC) associated with steatotic liver disease. The findings are published in the journal Cell Reports. Credit: